Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan Maternal and Infant Cohort Study

Environmental Health Perspectives

Volumn 122, Issue 5, 2014, Pages 529-534

  Wang, Yan ^a   Rogan, Walter J ^a   Chen, Pau Chung ^b,c   Lien, Guang Wen ^b   Chen, Hsiao Yen ^d   Tseng, Ying Chih ^e   Longnecker, Matthew P ^a   Wang, Shu Li ^a,d,f  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL EFFLUENT; LIOTHYRONINE; PERFLUOROALKYL SUBSTANCE; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG; DECANOIC ACID DERIVATIVE; FLUOROCARBON; PERFLUORODECANOIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERVIEW; LIMIT OF QUANTITATION; LONGITUDINAL STUDY; POLLUTANT; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SOCIOECONOMICS; TAIWAN; UMBILICAL CORD; BLOOD; NEWBORN; PREGNANCY; TOXICITY;

COHORT STUDIES; DECANOIC ACIDS; FEMALE; FLUOROCARBONS; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; TAIWAN; THYROID HORMONES;

EID: 84899759146     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306925     Document Type: Article

References (38)

1. Andersen M. E, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL Jr, Lau C, et al. 2008. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 102:3-14.
2. Belsley D. A, Kuh E, Welsch RE. 1980. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York:John Wiley & Sons.
3. Boas M., Forman JL, Juul A, Feldt-Rasmussen U, Skakkebaek N. E, Hilsted L, et al. 2009. Narrow intraindividual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women. Eur J Endocrinol 161:903-910.
4. Calafat A. M, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602; doi:10.1289/ehp.10598.
5. Chan E., Burstyn I, Cherry N, Bamforth F, Martin JW. 2011. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 111:559-564.
6. Chang S. C, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork J. A, Froehlich JW, et al. 2008. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 243:330-339.
7. Contempre B., Jauniaux E, Calvo R, Jurkovic D, Campbell S, de Escobar GM. 1993. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 77:1719-1722.
8. Dallaire R., Dewailly É, Pereg D, Dery S, Ayotte P. 2009. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 117:1380-1386; doi:10.1289/ehp.0900633.
9. Fei C., McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677-1682; doi:10.1289/ehp.10506.
10. Fisher D.A. 1997. Fetal thyroid function: Diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 40:16-31.
11. Fromme H., Tittlemier SA, Volkel W, Wilhelm M, Twardella D. 2009. Perfluorinated compounds-exposure assessment for the general population in western countries. Int J Hyg Environ Health 212:239-270.
12. Goecke-Flora C. M, Reo NV. 1996. Influence of carbon chain length on the hepatic effects of perfluorinated fatty acids. A 19Fand 31P-NMR investigation. Chem Res Toxicol 9:689-695.
13. Gutzkow K. B, Haug LS, Thomsen C, Sabaredzovic A, Becher G, Brunborg G. 2012. Placental transfer of perfluorinated compounds is selective-a Norwegian mother and child sub-cohort study. Int J Hyg Environ Health 215:216-219.
14. Harada K. H, Hitomi T, Niisoe T, Takanaka K, Kamiyama S, Watanabe T., et al. 2011. Odd-numbered perfluorocarboxylates predominate over perfluorooctanoic acid in serum samples from Japan, Korea and Vietnam. Environ Int 37:1183-1189.
15. Hoffman K., Webster TF, Weisskopf MG, Weinberg J, Vieira V.M. 2010. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ Health Perspect 118:1762-1767; doi:10.1289/ehp.1001898.
16. Houde M., Martin JW, Letcher RJ, Solomon KR, Muir DC. 2006. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 40:3463-3473.
17. Hume R., Simpson J, Delahunty C, van Toor H, Wu SY, Williams F. L, et al. 2004. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J Clin Endocrinol Metab 89:4097-4103.
18. Idris I., Srinivasan R, Simm A, Page RC. 2005. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf) 63:560-565.
19. Kim S., Choi K, Ji K, Seo J, Kho Y, Park J, et al. 2011. Transplacental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol 45:7465-7472.
20. Knox S. S, Jackson T, Frisbee SJ, Javins B, Ducatman AM. 2011. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci 36:403-410.
21. Kudo N., Suzuki E, Katakura M, Ohmori K, Noshiro R, Kawashima Y. 2001. Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem Biol Interact 134:203-216.
22. Lau C., Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
23. Lau C., Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton M. E, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74:382-392.
24. Lien G. W, Wen TW, Hsieh WS, Wu KY, Chen CY, Chen PC. 2011. Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/ tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879:641-646.
25. Lin C. Y, Wen LL, Lin LY, Wen TW, Lien GW, Hsu SH, et al. 2013. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. J Hazard Mater 244-245:637-644.
26. Luebker D. J, York RG, Hansen KJ, Moore JA, Butenhoff JL. 2005. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215:149-169.
27. Maisonet M., Terrell ML, McGeehin MA, Christensen KY, Holmes A., Calafat AM, et al. 2012. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect 120:1432-1437; doi:10.1289/ehp.1003096.
28. Olsen G. W, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff J. L, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305; doi:10.1289/ehp.10009.
29. Richardson D. B, Ciampi A. 2003. Effects of exposure measurement error when an exposure variable is constrained by a lower limit. Am J Epidemiol 157:355-363.
30. Rothman K.J. 1990. No adjustments are needed for multiple comparisons. Epidemiology 1:43-46.
31. Sahu M. T, Das V, Mittal S, Agarwal A, Sahu M. 2010. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 281:215-220.
32. Seacat A. M, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff J.L. 2002. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 68:249-264.
33. Soldin O. P, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N., Soldin SJ. 2004. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid 14:1084-1090.
34. Thibodeaux J. R, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards J. H, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74:369-381.
35. Vulsma T., Gons MH, de Vijlder JJ. 1989. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 321:13-16.
36. Washino N., Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, et al. 2009. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117:660-667; doi:10.1289/ehp.11681.
37. Weiss J. M, Andersson PL, Lamoree MH, Leonards PE, van Leeuwen S. P, Hamers T. 2009. Competitive binding of polyand perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci 109:206-216.
38. Yu W. G, Liu W, Jin YH. 2009. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem 28:990-996.